{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260803578717/en/Seaport-Therapeutics-Reports-Second-Quarter-2026-Financial-Results-and-Highlights-Recent-Corporate-and-Clinical-Progress", "message": "News view counter 865195 successfully enlarged"}